Recombinant antibody technology addressed many problems associated with hybridoma-based platforms for biologics production, opening the door to new classes of drugs.
Sponsored by:
Articles
Lead Generation
With 1,000+ new proteins in R&D each year, Sino Biological has extensive experience in producing recombinant proteins such as transmembrane proteins, enzymes, kinases, viral antigens, etc
Sino Biological is committed to providing scientific research institutions and pharmaceutical companies with one-stop custom antibody production services, from antigen synthesis to antibody generation and manufacturing.
Sino Biological is a contract research organization that specializes in recombinant production of proteins and antibodies, with routine high throughput projects of up to 1,000 per batch
Membrane proteins play a vital role in cellular activities, so much so that their abnormal function is related to many human diseases. In addition, membrane proteins are important drug targets, but its production is challenging due to factors such as low expression, difficult preparation, and poor stability.